Business · 03/04/2020Updated: 10/17/2026 · 1 min read
FDA Submits Proposed Collection of Information for Review Under Paperwork Reduction Act
Summary
The Food and Drug Administration (FDA) has submitted a proposed collection of information to the Office of Management and Budget (OMB) for review and clearance, aiming to reduce the risk of transfusion-transmitted infection in whole blood and blood components
Original source language: Federal Register — Food and Drug AdministrationOpen original release →